TM4SF1 and pancreatic neoplasm: In our study, we provided the evidence that TM4SF1 was more highly expressed in pancreatic cell lines than in normal pancreatic epithelial (HPDE) cells and gemcitabine resistance in pancreatic cancer cells could result from the expression of TM4SF1.